OpGen’s Bet on Precision Antibiotics

article image
ARTICLE SUMMARY:

The journey of OpGen, founded by some heavy hitters in diagnostics, illustrates how much the once-staid field of microbiology is changing and also demonstrates the challenges of applying big-data science and digital approaches to precision medicine initiatives.

As a data science revolution sweeps through healthcare, infectious disease has been behind the eight ball in applying new technologies to solve its challenges, but it is catching up.

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: